2023

From 2016 through 2020, Medicare Part B paid roughly $3 billion for 17.1 million definitive drug testing services to 3.3 million…

The United States International Trade Commission (USITC) is investigating the impact of expanding the waiver of intellectual…

On January 30, 2023, the White House issued a statement that the Biden Administration will end the COVID-19 public health…

The Biden administration proposed three pilot programs aimed at lowering costs and improving access to drugs under Medicare and…

On February 9, 2023, the Centers for Medicare & Medicaid Services (CMS) published two “initial” guidance documents (Part B and…

AMGA recently sent a letter to the Federal Trade Commission (FTC) regarding the agency’s proposed Non-Compete Clause Rule,…

Laurence Doud, III, the former CEO of the Rochester Drug Co-Operative, Inc. (RDC) was recently sentenced to 27 months in prison…

The United States Department of Justice (DOJ) recently announced an $825,000 settlement with a neurosurgeon and his fiancée over…

The Inflation Reduction Act had far-reaching implications for the health care industry, including the timeline Congress set for…

California Attorney General Rob Bonta recently announced a settlement with The Pill Club, an online women’s pharmacy, over…